is a drug discovery company focused on neurodegenerative disease. Cajal is inspired by the pioneering work of Nobel laureate Santiago Ramón y Cajal who illuminated the complexity of the brain by marrying art and science.
Location: United States, Washington, Seattle
Total raised: $96M
Investors 3
| Date | Name | Website |
| 26.02.2021 | Dolby Fami... | dolbyventu... |
| 22.11.2023 | Two Sigma ... | twosigmave... |
| 28.10.2020 | Lux Capita... | luxcapital... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.11.2022 | Series A | $96M | - |
Mentions in press and media 6
| Date | Title | Description |
| 23.01.2023 | Startups measuring the brain that you need to know | Companies are using biomarkers to diagnose and treat mental illness and other neurological disorders Mental illness is considered the silent pandemic that's been overlooked since the start of COVID. The World Health Organization found the g... |
| 29.11.2022 | Cajal Neuroscience Launches with $96 Million to Transform Target and Drug Discovery in Neurodegeneration | - |
| 29.11.2022 | Cajal Neuroscience Raises $96M in Series A Funding | Cajal Neuroscience, a Seattle, WA-based biotechnology company, raised $96M in Series A funding. The round was led by The Column Group and Lux Capital, with participation from Two Sigma Ventures, Evotec, Bristol Myers Squibb, Alexandria Vent... |
| 29.11.2022 | Seattle startup with fresh approach to Parkinson’s and Alzheimer’s disease raises $96M | Microscopy image of neurons in the mouse brain. (Cajal Neuroscience Image) Cajal Neuroscience, a Seattle startup taking a unique approach to developing treatments for neurodegenerative diseases like Alzheimer’s and Parkinson’s, revealed mor... |
| 14.01.2022 | Our 2021 Predictions Report Card: How Accurate Were We? | Each year we pause to reflect on what happened in the tech and VC space and share new predictions for the coming year. Last year, we shared 10 forecasts and tech trends that we expected to see in 2021, and now we’re looking back and judging... |
| - | Cajal Neuroscience | “Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.” |